1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Executive Summary: Global Contrast Media Market 

4.1. Industry Value Chain Analysis
4.1.1. Material provider
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User

4.2. Industry Outlook
4.2.1. Total number of new cases according to cancer type, 2023

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2019 - 2032
4.7.2. Market Volume Estimates and Forecast (000 Liters), 2019 - 2032
4.7.3. Price Trend Analysis

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping  

5.1. Key Insights

5.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
5.2.1. Iodine 
5.2.1.1. Ionic 
5.2.1.2. Non-Ionic 
5.2.2. Barium-Sulfate 
5.2.3. Gadolinium
5.2.4. Microbubbles
5.2.5. Others

6.1. Key Insights

6.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
6.2.1. Liquid 
6.2.2. Tablet 
6.2.3. Powder
6.2.4. Paste 

7.1. Key Insights

7.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
7.2.1. Oral route 
7.2.2. Rectal Route
7.2.3. Intravenous Route 
7.2.4. Intramuscular Route 
7.2.5. Intra-Arterial
7.2.6. Intradermal
7.2.7. Others 

8.1. Key Insights

8.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
8.2.1. X-Ray
8.2.2. Computed Tomography (CT)
8.2.3. Magnetic Resonance Imaging (MRI)
8.2.4. Ultrasound
8.2.5. Others

9.1. Key Insights

9.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
9.2.1. Cardiovascular Disorders
9.2.2. Cancer
9.2.3. Gastrointestinal Disorders
9.2.4. Neurological Disorders
9.2.5. Nephrological Disorders
9.2.6. Musculoskeletal Disorders
9.2.7. Others

10.1. Key Insights

10.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
10.2.1. Radiology
10.2.2. Interventional radiology
10.2.3. Interventional Cardiology
10.2.4. Others

11.1. Key Insights

11.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
11.2.1. Hospitals
11.2.2. Clinic 
11.2.3. Diagnostics Centre 
11.2.4. Others

12.1. Key Insights

12.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
12.2.1. North America
12.2.1.1. The U.S.
12.2.1.2. Canada
12.2.1.3. Mexico
12.2.2. Europe
12.2.2.1. Western Europe
12.2.2.1.1. The UK
12.2.2.1.2. Germany
12.2.2.1.3. France
12.2.2.1.4. Rest of Western Europe
12.2.2.2. Eastern Europe
12.2.2.2.1. Italy
12.2.2.2.2. Spain
12.2.2.2.3. Poland 
12.2.2.2.4. Russia
12.2.2.2.5. Rest of Eastern Europe
12.2.3. Asia Pacific
12.2.3.1. China
12.2.3.2. India
12.2.3.3. Japan
12.2.3.4. South Korea
12.2.3.5. Australia & New Zealand
12.2.3.6. ASEAN
12.2.3.7. Rest of Asia Pacific
12.2.4. Middle East & Africa
12.2.4.1. UAE
12.2.4.2. Saudi Arabia
12.2.4.3. South Africa
12.2.4.4. Rest of MEA
12.2.5. South America
12.2.5.1. Argentina
12.2.5.2. Brazil
12.2.5.3. Rest of South America

13.1. Key Insights

13.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
13.2.1. By Type 
13.2.2. By Formulation 
13.2.3. By Route of Administration 
13.2.4. By Modality 
13.2.5. By Indication 
13.2.6. By Application 
13.2.7. By End Users
13.2.8. By Country 

14.1. Key Insights

14.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
14.2.1. By Type 
14.2.2. By Formulation 
14.2.3. By Route of Administration 
14.2.4. By Modality 
14.2.5. By Indication 
14.2.6. By Application 
14.2.7. By End Users
14.2.8. By Country

15.1. Key Insights

15.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
15.2.1. By Type 
15.2.2. By Formulation 
15.2.3. By Route of Administration 
15.2.4. By Modality 
15.2.5. By Indication 
15.2.6. By Application 
15.2.7. By End Users
15.2.8. By Country

16.1. Key Insights

16.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
16.2.1. By Type 
16.2.2. By Formulation 
16.2.3. By Route of Administration 
16.2.4. By Modality 
16.2.5. By Indication 
16.2.6. By Application 
16.2.7. By End Users
16.2.8. By Country

17.1. Key Insights

17.2. Market Size and Forecast, 2019 - 2032 (US$ Mn and 000 Liters)
17.2.1. By Type 
17.2.2. By Formulation 
17.2.3. By Route of Administration 
17.2.4. By Modality 
17.2.5. By Indication 
17.2.6. By Application 
17.2.7. By End Users
17.2.8. By Country

18.1. Bayer AG
18.2. Beijing Beilu Pharmaceutical Co., Ltd.
18.3. Bracco Imaging SPA
18.4. Congruent Pharmachem Private Limited
18.5. GE Healthcare
18.6. Guerbet
18.7. iMAX
18.8. Lantheus Medical Imaging, Inc.
18.9. Nano Therapeutics Pvt. Ltd.
18.10. Novalek Pharmaceuticals Pvt. Ltd
18.11. Rege Imaging & Cine Films Private Limited
18.12. Stanex Drugs & Chemical Pvt. Ltd.
18.13. Taejoon Pharm 
18.14. Trivitron Healthcare Pvt. Ltd.
18.15. YRP Group
18.16. Other Prominent Players